Gabapentin and Pregabalin Offender Health Audit Report and Audit Tool

Sarah Cavanagh, Deputy Director, Medicines Use and Safety Division, Specialist Pharmacy ServiceSource Medicines Use and Safety Team Published

This report and associated survey and audit tool describe the process and outcomes of an England-wide collaborative audit and survey of the use of gabapentin and pregabalin in HM prisons and Immigration Removal Centres (IRCs) completed in October 2012. Both these medicines are known anecdotally and via some published evidence to be highly sought after by patients attending healthcare for their own use or for trading. These medicines are licensed for neuropathic pain, epilepsy and generalised anxiety disorder (GAD) and there is NICE guidance for each of these conditions. In addition, the survey explored the medical and pharmacy workforce available at each site to provide a picture of this workforce and whether the use of locum medical staff and access to in-site pharmacy staff influences the prescribing pattern for these medicines.

The audit and survey were designed to provide comprehensive medicines use data for comparative purposes across prisons and IRCs for these medicines and to provide a tested process for replication in the future locally or nationally when analysis of prescribing of other medicines is needed.

The audit/survey tool used is also attached here. This can be used by prisons and adapted for other healthcare environments or adapted for examining the use of other medicines. For further information please contact .